How have TRIB shares performed in 2024?

Trinity Biotech's stock was trading at $2.1450 at the beginning of the year. Since then, TRIB stock has decreased by 11.0% and is now trading at $1.91. View the best growth stocks for 2024 here .

Are investors shorting Trinity Biotech?

Trinity Biotech saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 1,200 shares, a drop of 72.1% from the March 15th total of 4,300 shares. Based on an average trading volume of 93,300 shares, the short-interest ratio is presently 0.0 days. Currently, 0.0% of the shares of the company are short sold. View Trinity Biotech's Short Interest .

When is Trinity Biotech's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 4th 2024. View our TRIB earnings forecast .

How were Trinity Biotech's earnings last quarter?

Trinity Biotech plc (NASDAQ:TRIB) posted its quarterly earnings results on Wednesday, January, 31st. The company reported ($0.90) earnings per share (EPS) for the quarter. The company had revenue of $14.68 million for the quarter.

When did Trinity Biotech's stock split?

Trinity Biotech shares reverse split on Wednesday, February 21st 2024. The 1-5 reverse split was announced on Wednesday, February 21st 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, February 21st 2024. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

What is Ronan O'Caoimh's approval rating as Trinity Biotech's CEO?

20 employees have rated Trinity Biotech Chief Executive Officer Ronan O'Caoimh on Glassdoor.com . Ronan O'Caoimh has an approval rating of 8% among the company's employees. This puts Ronan O'Caoimh in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Trinity Biotech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Trinity Biotech investors own include Gilead Sciences (GILD) , Novavax (NVAX) , OPKO Health (OPK) , Sorrento Therapeutics (SRNE) , Advanced Micro Devices (AMD) , Netflix (NFLX) , Pfizer (PFE) , QUALCOMM (QCOM) , Energy Transfer (ET) and Exxon Mobil (XOM) .

How do I buy shares of Trinity Biotech?

Shares of TRIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:TRIB

Trinity Biotech (TRIB) Stock Price, News & Analysis

→ Elon Musk’s ChatGPT Could Soon Mint New Millionaires (From InvestorPlace) (Ad)

Free TRIB Stock Alerts

$1.91

+0.05 (+2.69%)

(As of 04/15/2024 ET)

Compare

Today's Range: $1.84
▼
$1.92
50-Day Range: $0.45
▼
$2.85
52-Week Range: $1.81
▼
$6.20

Volume: 5,278 shs
Average Volume: 18,656 shs
Market Capitalization: $14.55 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get Trinity Biotech alerts:

Trinity Biotech MarketRank™ Stock Analysis

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Healthy
0.02% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.48
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($1.50) to $0.50 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.85 out of 5 stars

Medical Sector

844th out of 928 stocks

Diagnostic Substances Industry

11th out of 12 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for Trinity Biotech.

5.0

Short Interest

Percentage of Shares Shorted
0.02% of the float of Trinity Biotech has been sold short.
Short Interest Ratio / Days to Cover
Trinity Biotech has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Trinity Biotech has recently decreased by 72.09%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Trinity Biotech does not currently pay a dividend.
Dividend Growth
Trinity Biotech does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for TRIB.

1.9

News and Social Media Coverage

News Sentiment
Trinity Biotech has a news sentiment score of 0.48. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Trinity Biotech this week, compared to 1 article on an average week.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Trinity Biotech insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 8.20% of the stock of Trinity Biotech is held by insiders.
Percentage Held by Institutions
78.97% of the stock of Trinity Biotech is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Trinity Biotech are expected to grow in the coming year, from ($1.50) to $0.50 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Trinity Biotech is -0.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Trinity Biotech is -0.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

See Top Rated MarketRank™ Stocks Here

Ad InvestorPlace

“Forget Tesla, this is Elon’s Next Big Thing”

According to Forbes, this breakthrough could define the future of AI. Most people don’t know about it… Because it was found 750 miles away from Silicon Valley.

Click here to see the details.

About Trinity Biotech Stock (NASDAQ:TRIB)

Trinity Biotech plc acquires, together with its subsidiaries, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also provides laboratory-testing services for Sjogren's syndrome, hearing loss, celiac disease, lupus, rheumatoid arthritis, systemic sclerosis, and other laboratory-testing services for autoimmune disorders. The company develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. In addition, the company sells raw materials to the life sciences industry and research institutes. It serves public health authorities, non-governmental organisations, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.

TRIB Stock Price History

30 days | 90 days | 365 days | Advanced Chart

TRIB Stock News Headlines

April 16, 2024 | americanbankingnews.com

StockNews.com Initiates Coverage on Trinity Biotech (NASDAQ:TRIB)

April 8, 2024 | bizjournals.com

Trinity Biotech will shutter Kansas City manufacturing plant

April 16, 2024 | InvestorPlace (Ad)

“Forget Tesla, this is Elon’s Next Big Thing”

According to Forbes, this breakthrough could define the future of AI. Most people don’t know about it… Because it was found 750 miles away from Silicon Valley.

April 8, 2024 | finance.yahoo.com

Trinity Biotech plc (NASDAQ:TRIB) Q4 2023 Earnings Call Transcript

April 8, 2024 | americanbankingnews.com

StockNews.com Begins Coverage on Trinity Biotech (NASDAQ:TRIB)

April 5, 2024 | finance.yahoo.com

Trinity Biotech PLC (TRIB) Q4 2023 Earnings Call Transcript Highlights: A Glimpse into ...

April 4, 2024 | investorplace.com

TRIB Stock Earnings: Trinity Biotech Misses EPS, Misses Revenue for Q4 2023

April 4, 2024 | finanznachrichten.de

Trinity Biotech plc: Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates

April 16, 2024 | InvestorPlace (Ad)

“Forget Tesla, this is Elon’s Next Big Thing”

According to Forbes, this breakthrough could define the future of AI. Most people don’t know about it… Because it was found 750 miles away from Silicon Valley.

April 4, 2024 | globenewswire.com

Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates

April 3, 2024 | markets.businessinsider.com

What Wall Street expects from Trinity Biotech's earnings

March 28, 2024 | globenewswire.com

Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results

March 20, 2024 | msn.com

European Equities Traded in the US as American Depositary Receipts Ease Wednesday

March 18, 2024 | msn.com

San Diego’s latest biotech, Contineum Therapeutics, files to go public

March 8, 2024 | finanznachrichten.de

Trinity Biotech plc: Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

March 8, 2024 | globenewswire.com

Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

February 23, 2024 | finance.yahoo.com

TRIB Mar 2024 2.500 put

February 21, 2024 | benzinga.com

Trinity Biotech Stock (NASDAQ:TRIB) Earnings Dates and Earning Calls

February 15, 2024 | finance.yahoo.com

Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change

February 15, 2024 | globenewswire.com

Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change

February 14, 2024 | msn.com

European Equities Traded in the US as American Depositary Receipts Move Higher in Wednesday Trading

February 13, 2024 | msn.com

Trinity Biotech to implement ADS ratio change

February 13, 2024 | finance.yahoo.com

Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change

February 11, 2024 | seekingalpha.com

Week In Review: I-Mab Morphs Into U.S.-Only Company, Sells China Assets For $80M

February 9, 2024 | msn.com

European Equities Traded in US as American Depositary Receipts Move Slightly Higher in Friday Trading

February 8, 2024 | finance.yahoo.com

Trinity Biotech to Present at Emerging Growth Conference

February 7, 2024 | finance.yahoo.com

Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code

See More Headlines

Receive TRIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 1/31/2024
Today: 4/15/2024
Next Earnings (Estimated): 7/04/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Diagnostic substances
Sub-Industry: N/A
Current Symbol: NASDAQ:TRIB
CUSIP: N/A
CIK: 888721
Web: www.trinitybiotech.com
Phone: (531) 276-9800
Fax: 353-1276-9888
Employees: 398
Year Founded: 1992

Profitability

EPS (Most Recent Fiscal Year): ($3.17)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-24,020,000.00
Net Margins: -42.26%
Pretax Margin: -64.98%
Return on Equity: N/A
Return on Assets: -36.02%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 2.60
Quick Ratio: 1.27

Sales & Book Value

Annual Sales: $56.83 million
Price / Sales: 0.26
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($3.14) per share
Price / Book: -0.61

Miscellaneous

Outstanding Shares: 7,620,000
Free Float: 6,997,000
Market Cap: $14.55 million
Optionable: Optionable
Beta: 1.21

Social Links

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

Mr. John Gillard (Age 43)
President, CEO, Company Secretary & Director
Comp: $863k
Mr. Ronan O'Caoimh (Age 68)
Founder & Director
Comp: $340k
Dr. James Walsh Ph.D. (Age 66)
Executive Director of Business Development & Executive Director
Comp: $20k
Mr. Des Fitzgerald
Interim Chief Financial Officer
Mr. Simon Dunne (Age 50)
Chief Accounting Officer
Dr. Gary Keating Ph.D. (Age 51)
Chief Technology Officer
Ms. Eibhlin Kelly (Age 40)
Chief Information Officer
Mr. Colm Molloy (Age 53)
Group Director of Human Resources & Culture

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

TRIB Stock Analysis - Frequently Asked Questions

How have TRIB shares performed in 2024?: Trinity Biotech's stock was trading at $2.1450 at the beginning of the year. Since then, TRIB stock has decreased by 11.0% and is now trading at $1.91.
View the best growth stocks for 2024 here.
Are investors shorting Trinity Biotech?: Trinity Biotech saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 1,200 shares, a drop of 72.1% from the March 15th total of 4,300 shares. Based on an average trading volume of 93,300 shares, the short-interest ratio is presently 0.0 days. Currently, 0.0% of the shares of the company are short sold.
View Trinity Biotech's Short Interest.
When is Trinity Biotech's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, July 4th 2024.
View our TRIB earnings forecast.
How were Trinity Biotech's earnings last quarter?: Trinity Biotech plc (NASDAQ:TRIB) posted its quarterly earnings results on Wednesday, January, 31st. The company reported ($0.90) earnings per share (EPS) for the quarter. The company had revenue of $14.68 million for the quarter.

When did Trinity Biotech's stock split?: Trinity Biotech shares reverse split on Wednesday, February 21st 2024. The 1-5 reverse split was announced on Wednesday, February 21st 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, February 21st 2024. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.
What is Ronan O'Caoimh's approval rating as Trinity Biotech's CEO?: 20 employees have rated Trinity Biotech Chief Executive Officer Ronan O'Caoimh on Glassdoor.com. Ronan O'Caoimh has an approval rating of 8% among the company's employees. This puts Ronan O'Caoimh in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Trinity Biotech own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Trinity Biotech investors own include Gilead Sciences (GILD), Novavax (NVAX), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Netflix (NFLX), Pfizer (PFE), QUALCOMM (QCOM), Energy Transfer (ET) and Exxon Mobil (XOM).
How do I buy shares of Trinity Biotech?: Shares of TRIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TRIB) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Trinity Biotech (TRIB) Stock Price, News & Analysis

Trinity Biotech MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Company Ownership

Earnings and Valuation

About Trinity Biotech Stock (NASDAQ:TRIB)

TRIB Stock Price History

TRIB Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Institutional Ownership

TRIB Stock Analysis - Frequently Asked Questions

Overall MarketRank^™